1. Home
  2. POLA vs MBIO Comparison

POLA vs MBIO Comparison

Compare POLA & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.98

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.13

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
MBIO
Founded
1979
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
4.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
POLA
MBIO
Price
$1.98
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.5K
98.0K
Earning Date
11-19-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,326,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$0.89
52 Week High
$5.75
$21.95

Technical Indicators

Market Signals
Indicator
POLA
MBIO
Relative Strength Index (RSI) 35.13 41.80
Support Level $2.15 $1.05
Resistance Level $2.23 $1.14
Average True Range (ATR) 0.14 0.08
MACD 0.02 -0.01
Stochastic Oscillator 33.93 24.04

Price Performance

Historical Comparison
POLA
MBIO

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: